Although the molecular actions of sphingolipids have not yet been confirmed in horses, a higher ceramide concentration is likely to decrease peripheral insulin sensitivity, leading to hyperinsulinemia instead of a normal insulin response. This evidence concerns the gene INS and Hyperinsulinemia.